Personalised medicine replaces the “one-size-fits-all” model with tailored treatments based on genetic and molecular profiles. The article shows how multiplex diagnostics—decentralised, modular and integrable—enable faster and more sustainable treatment pathways, with Ulisse Biomed as the infrastructure enabler.

Modular qPCR testing quantifies Akkermansia, Faecalibacterium, Lactobacillus and Bifidobacterium within hours, enabling customised pathways and Diagnostics as a Service models.

Decentralised molecular diagnostics are revolutionising the rapid identification of respiratory infections. Thanks to portable multiplex real-time PCR systems, it is now possible to obtain accurate diagnoses of influenza, RSV, SARS-CoV-2 and other diseases on-site, optimising reporting times and supporting timely clinical decisions.

Core Lab or Point-of-Care? True innovation is in the synergy. A reasoned comparison of two complementary architectures of modern diagnostics.